Edition:
United States

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

10.48USD
20 Jul 2018
Change (% chg)

$-0.37 (-3.41%)
Prev Close
$10.85
Open
$10.82
Day's High
$11.05
Day's Low
$10.23
Volume
27,609
Avg. Vol
37,454
52-wk High
$17.54
52-wk Low
$7.45

Select another date:

Thu, May 3 2018

BRIEF-Corvus Pharmaceuticals Q1 Loss Per Share $0.63

* CORVUS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Adams Street Partners Reports 15.5 Pct Stake In Corvus Pharma

* ADAMS STREET PARTNERS, LLC REPORTS 15.5 PERCENT STAKE IN CORVUS PHARMACEUTICALS INC AS OF MARCH 12, 2018 - SEC FILING‍​

BRIEF-BVF Partners Reports 6.7 Pct Passive Stake In Corvus Pharmaceuticals

* BVF PARTNERS L.P. REPORTS 6.7 PERCENT PASSIVE STAKE IN CORVUS PHARMACEUTICALS INC AS OF MARCH 8, 2018 - SEC FILING‍​ Source text: (http://bit.ly/2G67UVx) Further company coverage:

BRIEF-Corvus Pharma Announces Pricing Of Public Offering Of Common Stock

* CORVUS PHARMACEUTICALS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

BRIEF-Corvus Pharma Announces Proposed Public Offering Of Common Stock

* CORVUS PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Corvus Pharmaceuticals Qtrly Net Loss Per Share $0.58

* CORVUS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Select another date: